close

Agreements

1 2 3 4 242
Number of results: 4836

Excel print is not allowed for data more than 3000.Please search above for fewer data.

Date Company Compound Disease Type of agreement Therapeutic area Type of Information
2018-09-27 Cellular Biomedicine Group (China) Novartis (Switzerland) Kymriah® - CTL019 (tisagenlecleucel-T) manufacturing - production Cancer - Oncology - Technology - Services Production agreement
2018-09-27 Cellular Biomedicine Group (China) Novartis (Switzerland) Kymriah® - CTL019 (tisagenlecleucel-T) manufacturing - production Cancer - Oncology - Technology - Services Production agreement
2018-09-27 Allogene Therapeutics (USA - CA) member of the board of directors nomination Cancer - Oncology Nomination
2018-09-27 BioInvent (Sweden) Cardiovax (USA - CA) orticumab (BI-204) production - manufacturing Inflammatory diseases - Technology Services Production agreement
2018-09-25 Cobra Biologics (Sweden) Centre for Process Innovation (CPI) (UK) GE Healthcare Life Sciences (USA - WI) manufacturing of adeno-associated virus (AAV) vectors collaboration Technology - Services Collaboration agreement
2018-09-21 InflaRx (Germany) member of the board nomination Inflammatory diseases Nomination
2018-09-19 Abzena (UK) Tmunity Therapeutics (USA - PA)
  • fully-humanized therapeutic antibodies devoid of CD4+ T cell epitopes
services contract Cancer - Oncology - Technology - Services Services contract
2018-09-19 Poietis (France) Servier (France) 4D bioprinting of liver tissues research - development - R&D Technology - Services Research agreement
2018-09-18 Thrombogenics (Belgium) Alcon (USA -TX), a Novartis subsidiary (Switzerland) Jetrea® (ocriplasmin) symptomatic vitreomacular adhesion commercialisation Ophtalmological diseases Termination of an agreement
2018-09-18 Tmunity Therapeutics (USA - PA) executive vice-president nomination Cancer - Oncology Nomination
2018-09-17 Respivant Sciences (USA - CA) nomination Lung diseases - Respiratory diseases - Rare diseases Nomination
2018-09-17 Fate Therapeutics (USA - CA) Ono Pharmaceutical (Japan) two off-the-shelf CAR-T cell product candidates lymphoblastic leukemias, solid tumors
  • development - commercialisation
Cancer - Oncology Development agreement
2018-09-17 Accenture (Ireland) Amazon (USA - CA) Merck&Co (USA - NJ) cloud-based informatics research platform collaboration Technology - Services Collaboration agreement
2018-09-14 Horizon Discovery (UK) AstraZeneca (UK) Edit-R™ crRNA libraries services contract Technology - Services Services contract
2018-09-13 Fate Therapeutics (USA - CA) J. David Gladstone Institutes (USA - CA) CRISPR-mediated gene activation licensing Technology - Services Licensing agreement
2018-09-13 Lysogene (France) resignation Rare diseases - Genetic diseases Resignation
2018-09-12 Imcheck Therapeutics (France) chief scientific officer (CSO) nomination Cancer - Oncology - Autoimmune diseases Nomination
2018-09-11 Optibrium (UK) Intellegens (UK) predictive modelling platform for drug discovery development Technology - Services Development agreement
2018-09-11 Akero Therapeutics (USA - CA) president and ceo nomination Liver diseases - Hepatic diseases Nomination
2018-09-11 SGS (Switzerland) new testing capabilities at Lincolnshire facility construction of new premises Technology - Services Construction of new premises